Updates on attention deficit hyperactivity disorder, child abuse and neglect, and sudden infant death syndrome.
Daley
Katie Campbell
KC
Department of Medicine, Children's Hospital, Boston, Massachusetts, USA. Katie_Daley@vmed.org
D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use; D000662:Amphetamines / Q000627:therapeutic use; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D002649:Child Abuse; D002650:Child Abuse, Sexual / Q000175:diagnosis / Q000523:psychology; D003891:Desipramine / Q000627:therapeutic use; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008774:Methylphenidate / Q000627:therapeutic use; D016684:Prone Position; D011437:Propylamines / Q000627:therapeutic use; D012307:Risk Factors; D013398:Sudden Infant Death / Q000453:epidemiology / Q000517:prevention & control
C090411:Adderall; D018759:Adrenergic Uptake Inhibitors; D000662:Amphetamines; D000697:Central Nervous System Stimulants; D018765:Dopamine Uptake Inhibitors; D011437:Propylamines; D008774:Methylphenidate; D000069445:Atomoxetine Hydrochloride; D003891:Desipramine